5 Jun | CUREator+ Dementia & Cognitive Decline Information Session

The CUREator+ Dementia and Cognitive Decline incubator program, a partnership between Brandon BioCatalyst, ANDHealth and Dementia Australia, has opened its first funding round!

Companies pioneering innovative health technologies to enhance the lives of individuals affected by dementia and cognitive decline can receive up to $5 million per project in non-dilutive project funding, a substantial boost for their innovative solutions.

Funded by the Federal Government’s Medical Research Future Fund (MRFF), the program aims to support the development of novel approaches, spanning therapeutics, diagnostics, assistive and medical devices and digital health technologies, that will prolong or improve the lives of the estimated 421,000 Australians currently living with Dementia and the 1.6 million caregivers who support them.

Applications for CUREator+ Dementia and Cognitive Decline are now open to entrepreneurial researchers, clinical innovators and founders across Australia.

Attend this information session to learn more about the program, eligibility and the application process.